Single Participant Study of an Experimental ASO Treatment for TUBB4A-related Leukodystrophyfor Genetic Disease1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 4+Code: NCT06369974·Phase 1, Phase 2·Enrolling By Invitation
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulatorsfor Cystic Fibrosis68 locations incl. BirminghamSponsor: Nicole HamblettSex: All·Age: 12+Code: NCT06504589·RecruitingApply to this trial
Emapalumab Prevention of CAR-T Cell Associated Toxicitiesfor Large B-cell Lymphoma2 locations incl. BostonSponsor: Marcela V. Maus, M.D.,Ph.D.Sex: All·Age: 18+Code: NCT06550141·Phase 2·RecruitingApply to this trial
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Womenfor Coronary Artery Disease18 locations incl. GlendaleSponsor: Weill Medical College of Cornell UniversitySex: All·Age: 18+Code: NCT06399692·Phase 3·RecruitingApply to this trial
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopeniafor Immune Thrombocytopenia1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06817395·RecruitingApply to this trial
Initial Resuscitation for Acute Kidney Injury in Cirrhosisfor Cirrhosis, Liver1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06525623·RecruitingApply to this trial
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumorsfor Pancreatic Ductal Adenocarcinoma25 locations incl. DuarteSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06586515·Phase 1·RecruitingApply to this trial
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)for Treatment Resistant Depression24 locations incl. BirminghamSponsor: Abbott Medical DevicesSex: All·Age: 22 - 70Code: NCT06423430·RecruitingApply to this trial
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmfor Coronary Artery Disease18 locations incl. ChandlerSponsor: Kardion IncSex: All·Age: 18 - 90Code: NCT06445608·RecruitingApply to this trial
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myelomafor Multiple Myeloma50 locations incl. GilbertSponsor: Kite, A Gilead CompanySex: All·Age: 18+Code: NCT06413498·Phase 3·RecruitingApply to this trial
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypassfor Acquired Antithrombin Deficiency9 locations incl. StanfordSponsor: OctapharmaSex: All·Age: 18 - 85Code: NCT06096116·Phase 3·RecruitingApply to this trial
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)for Chronic Inflammatory Demyelinating PolyneuropathyDrug: riliprubart29 locations incl. HomewoodSponsor: SanofiSex: All·Age: 18+Code: NCT06290141·Phase 3·RecruitingApply to this trial
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancerfor Lung Cancer3 locations incl. Los AngelesSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06427954·RecruitingApply to this trial
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancersfor Epithelial Ovarian Cancer5 locations incl. BostonSponsor: Regeneron PharmaceuticalsSex: Female·Age: 18+Code: NCT06469281·Phase 1·RecruitingApply to this trial
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injuryfor Traumatic Brain Injury18 locations incl. San FranciscoSponsor: University of California, San FranciscoSex: All·Age: 18 - 65Code: NCT05826912·Phase 2·Enrolling By Invitation
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetesfor Gestational Diabetes Mellitus21 locations incl. TuscaloosaSponsor: Ohio State UniversitySex: Female·Age: 18+Code: NCT06445946·Phase 4·RecruitingApply to this trial
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.for Generalized Myasthenia GravisDrug: Iptacopan21 locations incl. ScottsdaleSponsor: Novartis PharmaceuticalsSex: All·Age: 18 - 85Code: NCT06517758·Phase 3·RecruitingApply to this trial
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)for Tricuspid Regurgitation36 locations incl. PhoenixSponsor: P+F Products + Features USA Inc.Sex: All·Age: 18+Code: NCT06137807·RecruitingApply to this trial
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)for Locally Advanced Solid Tumor17 locations incl. IrvineSponsor: Nuvalent Inc.Sex: All·Age: 18+Code: NCT06521554·Phase 1·RecruitingApply to this trial
Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONlinefor Overweight, Childhood1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 4 - 17Code: NCT06432790·RecruitingApply to this trial
Blood Pressure Variability and Ischemic Stroke Outcomefor Acute Ischemic Stroke3 locations incl. New HavenSponsor: Yale UniversitySex: All·Age: 18+Code: NCT05756257·RecruitingApply to this trial
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Workfor Chronic Inflammatory Demyelinating PolyradiculoneuropathyDrug: riliprubart27 locations incl. HomewoodSponsor: SanofiSex: All·Age: 18+Code: NCT06290128·Phase 3·RecruitingApply to this trial
Study to Determine the Clinical Significance of Intravascular OCT-NIRAFfor Cardiovascular Diseases1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06374498·Enrolling By Invitation
Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patientsfor Fibromyalgia1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 80Code: NCT06009159·RecruitingApply to this trial
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumorsfor Metastatic Solid TumorDrug: LY405203117 locations incl. DuarteSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06465069·Phase 1·RecruitingApply to this trial
Global Paradise System US Post Approval Studyfor Hypertension39 locations incl. SacramentoSponsor: ReCor Medical, Inc.Sex: All·Age: 18+Code: NCT06297291·RecruitingApply to this trial
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndromefor Acute Respiratory Distress Syndrome33 locations incl. TucsonSponsor: Beth Israel Deaconess Medical CenterSex: All·Age: 18+Code: NCT06066502·Phase 3·RecruitingApply to this trial
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLfor Large B-cell Lymphoma60 locations incl. GilbertSponsor: Allogene TherapeuticsSex: All·Age: 18+Code: NCT06500273·Phase 2·RecruitingApply to this trial
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsyfor Mesial Temporal Lobe Epilepsy18 locations incl. BirminghamSponsor: UniQure Biopharma B.V.Sex: All·Age: 18 - 75Code: NCT06063850·Phase 1, Phase 2·RecruitingApply to this trial
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumorsfor Biliary Tract Cancer6 locations incl. DenverSponsor: ModeX Therapeutics, An OPKO Health CompanySex: All·Age: 18+Code: NCT06239194·Phase 1, Phase 2·RecruitingApply to this trial
Ziftomenib Maintenance Post Allo-HCTfor Acute Myeloid Leukemia2 locations incl. BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT06440135·Phase 1·RecruitingApply to this trial
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)for Advanced MelanomaDrug: Nivolumab37 locations incl. TucsonSponsor: Immunocore LtdSex: All·Age: 18+Code: NCT06112314·Phase 3·RecruitingApply to this trial
Spastic Paraplegia - Centers of Excellence Research Networkfor Hereditary Spastic Paraplegia11 locations incl. MiamiSponsor: Boston Children's HospitalSex: All·Age: All agesCode: NCT06553976·RecruitingApply to this trial
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spreadfor Metastatic Breast Cancer29 locations incl. PhoenixSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06324357·Phase 1, Phase 2·RecruitingApply to this trial
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myelomafor Relapsed Cancer2 locations incl. BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05922501·Phase 2·RecruitingApply to this trial
Health Outcomes of Parents With Cystic Fibrosis-Aim 2for Cystic Fibrosis18 locations incl. BirminghamSponsor: University of PittsburghSex: All·Age: 18+Code: NCT06296394·RecruitingApply to this trial
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromefor Acute Myeloid LeukemiaDrug: Venetoclax9 locations incl. New HavenSponsor: Bristol-Myers SquibbSex: All·Age: 18+Code: NCT06419634·Phase 1·RecruitingApply to this trial
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumorsfor Colorectal Cancer32 locations incl. ChandlerSponsor: Revolution Medicines, Inc.Sex: All·Age: 18+Code: NCT06445062·Phase 1, Phase 2·RecruitingApply to this trial
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)for Hiv13 locations incl. BirminghamSponsor: Johns Hopkins UniversitySex: All·Age: 18+Code: NCT06263426·RecruitingApply to this trial
VE303 for Prevention of Recurrent Clostridioides Difficile Infectionfor Clostridium Difficile84 locations incl. HuntsvilleSponsor: Vedanta Biosciences, Inc.Sex: All·Age: 12+Code: NCT06237452·Phase 3·RecruitingApply to this trial